Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Feb;82(2):683-93.
doi: 10.1128/IAI.00855-13. Epub 2013 Nov 25.

Impact of surfactant protein D, interleukin-5, and eosinophilia on Cryptococcosis

Affiliations

Impact of surfactant protein D, interleukin-5, and eosinophilia on Cryptococcosis

Stephanie M Holmer et al. Infect Immun. 2014 Feb.

Abstract

Cryptococcus neoformans is an opportunistic fungal pathogen that initiates infection following inhalation. As a result, the pulmonary immune response provides a first line of defense against C. neoformans. Surfactant protein D (SP-D) is an important regulator of pulmonary immune responses and is typically host protective against bacterial and viral respiratory infections. However, SP-D is not protective against C. neoformans. This is evidenced by previous work from our laboratory demonstrating that SP-D-deficient mice infected with C. neoformans have a lower fungal burden and live longer than wild-type (WT) control animals. We hypothesized that SP-D alters susceptibility to C. neoformans by dysregulating the innate pulmonary immune response following infection. Thus, inflammatory cells and cytokines were compared in the bronchoalveolar lavage fluid from WT and SP-D(-/-) mice after C. neoformans infection. Postinfection, mice lacking SP-D have reduced eosinophil infiltration and interleukin-5 (IL-5) in lung lavage fluid. To further explore the interplay of SP-D, eosinophils, and IL-5, mice expressing altered levels of eosinophils and/or IL-5 were infected with C. neoformans to assess the role of these innate immune mediators. IL-5-overexpressing mice have increased pulmonary eosinophilia and are more susceptible to C. neoformans infection than WT mice. Furthermore, susceptibility of SP-D(-/-) mice to C. neoformans infection could be restored to the level of WT mice by increasing IL-5 and eosinophils by crossing the IL-5-overexpressing mice with SP-D(-/-) mice. Together, these studies support the conclusion that SP-D increases susceptibility to C. neoformans infection by promoting C. neoformans-driven pulmonary IL-5 and eosinophil infiltration.

PubMed Disclaimer

Figures

FIG 1
FIG 1
SP-D−/− mice are more resistant than WT mice to aerosol exposure of C. neoformans. (A) Mice were exposed to aerosolized H99 Stud in full-body Madison chambers, and fungal burden was assessed in the lung up to 21 days postinfection. Each time point was repeated at least twice for a total of 7 to 8 mice/group. Representative images from histological analyses of paraffin-embedded and H&E-stained lung tissue from WT mice (B) and SP-D−/− mice (C) after aerosol exposure are shown. *, P < 0.05; **, P < 0.01.
FIG 2
FIG 2
Total CD45+ cells are decreased in SP-D−/− mice compared to WT mice after C. neoformans infection. Flow cytometric analysis of total CD45+ cells in WT and SP-D−/− mice after C. neoformans infection in lung interstitium (day 3, n = 5 to 9 mice/group; day 7, n = 14 to 21 mice/group) (A) and lung BAL fluid (day 3, n = 1 to 2 samples/group; day 7, n = 5 to 8 samples/group; samples were pooled and normalized to per mouse cell counts) (B). Shown in panels A and B are absolute numbers of cells per mouse calculated from total cellularity obtained and the percentage of CD45+ cells. Frequency of PMNs in lung interstitium (C) and BAL fluid (D), of CD11c+ MHC-IIint cells in lung interstitium (E) and BAL fluid (F), of CD11c+ MHC-IIhi cells in lung interstitium (G) and BAL fluid (H), and of lymphocytes/other CD45+ cells in lung interstitium (I) and BAL fluid (J) are shown. In panels C to J, data are shown as percentages of CD45+ cells. *, P < 0.05 for WT infected versus SP-D−/− infected mice.
FIG 3
FIG 3
IL-5 production and eosinophil infiltration are reduced in infected SP-D−/− mice compared to levels in WT mice. WT and SP-D−/− mice were infected intranasally with 5 × 105 H99 Stud cells. (A) Eosinophils in BAL fluid were assessed at 7 days postinfection via cytospin and H&E staining (n = 3 to 11 mice/group). (B) IL-5 protein levels were measured at 3 days postinfection in BAL fluid by ELISA (n = 8 to 10 mice/group). (C) IL-5 mRNA steady-state level was measured on days 1 to 3 postinfection in postlavage lung tissue (n = 4 to 10 mice/group). (D) Mice were administered IL-5 neutralizing antibodies at the time of infection. Eosinophils were assessed in BAL fluid at 7 days postinfection via cytospin and H&E staining. For the IL-5 blockade, data are shown as frequency of the respective isotype-treated control (n = 12 to 14 mice/group). *, P < 0.05; **, P < 0.01; ***, P < 0.001. Photomicrographs show representative cytospins used for analysis of saline-treated WT mice (E), saline-treated SP-D−/− mice (F), C. neoformans-infected WT mice (G), and C. neoformans-infected SP-D−/− mice (H). Arrowheads indicate macrophages, and arrows indicate eosinophils.
FIG 4
FIG 4
IL-5-overexpressing mice are more susceptible to C. neoformans than WT mice. (A) Pulmonary fungal burden at 7 days post-C. neoformans infection in WT and IL-5Tg mice. ***, P < 0.001. (B) Survival analysis of WT and IL-5Tg mice (two independent experiments for a total of at least 18 mice/group; P < 0.0001).
FIG 5
FIG 5
IL-5 overexpression increases the susceptibility of SP-D−/− mice to C. neoformans. (A) Pulmonary fungal burden at 14 days post-C. neoformans infection in WT, IL-5Tg, SP-D−/−, and IL-5TgxSP-D−/− mice. *, P < 0.05; **, P < 0.01; ***, P < 0.001. (B) Survival analysis of WT, IL-5Tg, SP-D−/−, and IL-5TgxSP-D−/− mice (two independent experiments for a total of at least 3 mice/group; for the WT versus SP-D−/−, P <0.001; for the WT versus IL-5TgxSP-D−/−, not significant; for IL-5TgxSP-D−/− versus SP-D−/−, P < 0.05; and for IL-5TgxSP-D−/− versus IL-5Tg, P < 0.001).
FIG 6
FIG 6
Representative photomicrographs from H&E-stained lung sections 7 days after C. neoformans infection: WT sham-infected mice (A), WT C. neoformans-infected mice (B), SP-D−/− sham-infected mice (C), SP-D−/− C. neoformans-infected mice (D), IL-5Tg sham-infected mice (E), IL-5Tg C. neoformans-infected mice (F), IL-5TgxSP-D−/− sham-infected mice (G), and IL-5TgxSP-D−/− C. neoformans-infected mice (H). Arrows indicate C. neoformans cells; the cell wall of C. neoformans is stained by hematoxylin.

References

    1. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. 2009. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23:525–530. 10.1097/QAD.0b013e328322ffac - DOI - PubMed
    1. Jain AV, Zhang Y, Fields WB, McNamara DA, Choe MY, Chen Gh Erb-Downward J, Osterholzer JJ, Toews GB, Huffnagle GB, Olszewski MA. 2009. Th2 but Not Th1 immune bias results in altered lung functions in a murine model of pulmonary Cryptococcus neoformans Infection. Infect. Immun. 77:5389–5399. 10.1128/IAI.00809-09 - DOI - PMC - PubMed
    1. Muller U, Stenzel W, Kohler G, Werner C, Polte T, Hansen G, Schutze N, Straubinger RK, Blessing M, McKenzie AN, Brombacher F, Alber G. 2007. IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with Cryptococcus neoformans. J. Immunol. 179:5367–5377 - PubMed
    1. Hardison SE, Ravi S, Wozniak KL, Young ML, Olszewski MA, Wormley FL., Jr 2010. Pulmonary infection with an interferon-gamma-producing Cryptococcus neoformans strain results in classical macrophage activation and protection. Am. J. Pathol. 176:774–785. 10.2353/ajpath.2010.090634 - DOI - PMC - PubMed
    1. Chen Gh McNamara DA, Hernandez Y, Huffnagle GB, Toews GB, Olszewski MA. 2008. Inheritance of immune polarization patterns is linked to resistance versus susceptibility to Cryptococcus neoformans in a mouse model. Infect. Immun. 76:2379–2391. 10.1128/IAI.01143-07 - DOI - PMC - PubMed

Publication types

Substances